Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial

OBJECTIVE: This study evaluated subcutaneous injections of tetrodotoxin (TTX) for the treatment of moderate to severe, inadequately controlled cancer-related pain. METHODS: Eligible patients were randomized to receive TTX (30 μg) or placebo subcutaneously twice daily for four consecutive days. Effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagen, Neil A., Cantin, Lyne, Constant, John, Haller, Tina, Blaise, Gilbert, Ong-Lam, May, du Souich, Patrick, Korz, Walter, Lapointe, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438848/
https://www.ncbi.nlm.nih.gov/pubmed/28555092
http://dx.doi.org/10.1155/2017/7212713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438848/
https://www.ncbi.nlm.nih.gov/pubmed/28555092
http://dx.doi.org/10.1155/2017/7212713

Ejemplares similares